Physician

Nisha Lassi Jacobs, MD

According to 2025 Medicare claims, Nisha Jacobs, MD (NPI: 1134241391) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Anoka, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55433-2573. Jacobs is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Jacobs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 327 traditional Medicare patients, billed 96,459 HCPCS/CPT codes, and received $1,487,089 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 998 prescription claims across 194 beneficiaries totaling $2,905,467 in drug costs, led by Ojjaara (Momelotinib Dihydrochloride). DME data shows 51 claims. Open Payments data shows 1 records totaling $1,260. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $467,455 to $1,487,089. Similarly, Part D prescription costs have risen steadily, from $177,896 to $2,905,467. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $467,455 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $477,605 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $373,843 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $599,608 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,838,458 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,766,741 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,974,116 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,167,956 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,728,269 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,487,089 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201525943,708$467,455
201626037,264$477,605
201721932,596$373,843
201827947,855$599,608
2019570152,186$1,838,458
2020475142,998$1,766,741
2021445160,677$1,974,116
2022416165,400$2,167,956
2023398137,755$1,728,269
202432796,459$1,487,089

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $177,896 (USD; Tot_Drug_Cst)2016 Drug cost: $480,377 (USD; Tot_Drug_Cst)2017 Drug cost: $271,826 (USD; Tot_Drug_Cst)2018 Drug cost: $271,847 (USD; Tot_Drug_Cst)2019 Drug cost: $573,401 (USD; Tot_Drug_Cst)2020 Drug cost: $1,049,612 (USD; Tot_Drug_Cst)2021 Drug cost: $1,232,355 (USD; Tot_Drug_Cst)2022 Drug cost: $2,715,219 (USD; Tot_Drug_Cst)2023 Drug cost: $2,676,846 (USD; Tot_Drug_Cst)2024 Drug cost: $2,905,467 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015108632$177,896
2016141837$480,377
2017133747$271,826
2018146815$271,847
2019161833$573,401
2020158885$1,049,612
2021169875$1,232,355
20222011,212$2,715,219
20232191,234$2,676,846
2024194998$2,905,467

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.0K$8.0K2015 Medicare payment: $8,036 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,533 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $7,826 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,216 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,043 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,347 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,122 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R158$8,036
2016N/R127$4,533
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R69$7,826
2020N/R24$2,216
2021N/R33$5,043
2022N/R48$3,347
2023N/RN/RN/R
2024N/R51$1,122

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more109154$96
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's104160$13
80053Blood test, comprehensive group of blood chemicals153465$10
36415Insertion of needle into vein for collection of blood sample137419$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count158590$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OjjaaraMomelotinib Dihydrochloride12360$342,260
PomalystPomalidomide13364$291,661
InlytaAxitinib12360$233,311
VenclextaVenetoclax18525$221,052
VerzenioAbemaciclib14392$219,020

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R17$564
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R17$320
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R17$238

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$1,260Exelixis Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nisha Lassi Jacobs, MD?

Tedicare shows public-source Medicare data for Nisha Lassi Jacobs, MD (NPI 1134241391), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nisha Lassi Jacobs, MD have ACO affiliation data?

Nisha Lassi Jacobs, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Nisha Lassi Jacobs, MD?

Nisha Lassi Jacobs, MD is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Nisha Lassi Jacobs, MD have Open Payments data?

Nisha Lassi Jacobs, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.